Media
Media
Our latest press releases
Hansa Biopharma announces positive topline data from the imlifidase phase 2 study in antibody mediated rejection (AMR) episodes post kidney transplantation
Regulatory press release
28/11/2022
Hansa Biopharma and partner Sarepta Therapeutics plan to initiate a clinical study with imlifidase as a pre-treatment to Sarepta’s SRP-9001 gene therapy in DMD in 2023
Regulatory press release
02/11/2022
Hansa Biopharma: Increase of the number of shares and votes
Regulatory press release
31/10/2022
Hansa Biopharma Interim report January-September 2022
Regulatory press release
20/10/2022
Media
News and insights
Pride and commitment: how we shape Hansa into a truly great place to work
30/09/2022
Understanding the individual unmet needs of highly sensitized patients awaiting kidney transplant
10/03/2022
Time is a key factor: a spotlight on people affected by Guillain-Barré Syndrome
28/02/2022
A spotlight on anti-GBM disease
01/12/2021
Patient stories
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Employee stories
Working in an epicentre of pioneering innovation
“The key to our collective success at Hansa Biopharma goes far beyond our scientific breakthroughs, as it stems from the amazing team spirit we have built.”
Patient stories
Taking care of a transplanted kidney through physical and mental health
“And people say to me: I never would have guessed that you had a kidney transplant… when I hear those words, they keep me motivated, and keep me going.”
Patient stories
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
Meetings of interest
Impactful interaction with the scientific and medical community
At Hansa, we are focused on the bigger picture and want help rare disease patients live long and healthy lives. We do this also by constant engagement with the scientific and healthcare communities. We use this opportunity to not only raise awareness about the unmet needs of the patients, but also to help advance the understanding in these complex fields. Meetings of interest